NANOG and hepatocellular carcinoma: Oct4/Nanog co-expression is also a strong independent predictor of tumor recurrence and unfavorable outcome in hepatocellular carcinoma (HCC) by promoting EMT through activation of Stat3/Snail signaling [38].